SCHEMBL17486338

SCHEMBL17486338

CC(C)(C)c1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3)nc(-c3ccc(-c4ccc5c(c4)C(C)(C)CC5(C)C)nc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.39
RAB9A P51151 4/20 0.39
RARA P10276 3/20 0.35
RARB P10826 3/20 0.35
ALDH1A1 P00352 1/20 0.34
TDO2 P48775 1/20 0.34
RARG P13631 3/20 0.33
RXRA P19793 2/20 0.32
RXRB P28702 1/20 0.32
MAPT P10636 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ABL1 P00519 1/20 0.32
BCR P11274 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17485982 0.96 NPC1 (0.38) NPC1RAB9ARARARARBALDH1A1
SCHEMBL20805739 0.92 NPC1 (0.34) NPC1RAB9ARARARARBALDH1A1
SCHEMBL17485986 0.86 RARA (0.36) RARARARBRARGRXRA
SCHEMBL17486298 0.86 RARA (0.36) RARARARBRARGRXRA
SCHEMBL17486329 0.86 RARB (0.42) NPC1RAB9ARARARARBALDH1A1
SCHEMBL17486048 0.85 NPC1 (0.35) NPC1RAB9ARARARARBALDH1A1
SCHEMBL17486080 0.84 ALOX5AP (0.36) NPC1RAB9ARARARARBALDH1A1
SCHEMBL17486245 0.84 NPC1 (0.40) NPC1RAB9ARARARARBALDH1A1
SCHEMBL20805746 0.83 RAB9A (0.34) NPC1RAB9ARARARARBALDH1A1
SCHEMBL17486296 0.82 RARA (0.38) RARARARBRARGRXRAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 NPC1 3516/4885RAB9A 2201/4885RARA 3284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.